![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TIMM13 |
Gene summary for TIMM13 |
![]() |
Gene information | Species | Human | Gene symbol | TIMM13 | Gene ID | 26517 |
Gene name | translocase of inner mitochondrial membrane 13 | |
Gene Alias | TIM13 | |
Cytomap | 19p13.3 | |
Gene Type | protein-coding | GO ID | GO:0003008 | UniProtAcc | Q9Y5L4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
26517 | TIMM13 | HTA11_6818_2000001011 | Human | Colorectum | AD | 5.31e-10 | 6.38e-01 | 0.0112 |
26517 | TIMM13 | HTA11_7469_2000001011 | Human | Colorectum | AD | 1.76e-14 | 9.22e-01 | -0.0124 |
26517 | TIMM13 | HTA11_11156_2000001011 | Human | Colorectum | AD | 1.34e-08 | 7.06e-01 | 0.0397 |
26517 | TIMM13 | HTA11_6818_2000001021 | Human | Colorectum | AD | 5.51e-08 | 3.99e-01 | 0.0588 |
26517 | TIMM13 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.73e-32 | 8.07e-01 | 0.294 |
26517 | TIMM13 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 4.40e-10 | 9.85e-01 | 0.3487 |
26517 | TIMM13 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 2.63e-40 | 1.06e+00 | 0.281 |
26517 | TIMM13 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.55e-57 | 1.29e+00 | 0.3859 |
26517 | TIMM13 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 2.16e-19 | 6.70e-01 | 0.2585 |
26517 | TIMM13 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.42e-35 | 6.96e-01 | 0.3005 |
26517 | TIMM13 | AEH-subject1 | Human | Endometrium | AEH | 9.26e-13 | -3.59e-01 | -0.3059 |
26517 | TIMM13 | AEH-subject2 | Human | Endometrium | AEH | 7.46e-12 | -3.07e-01 | -0.2525 |
26517 | TIMM13 | AEH-subject3 | Human | Endometrium | AEH | 3.38e-09 | -2.31e-01 | -0.2576 |
26517 | TIMM13 | AEH-subject4 | Human | Endometrium | AEH | 5.58e-24 | -6.24e-01 | -0.2657 |
26517 | TIMM13 | AEH-subject5 | Human | Endometrium | AEH | 3.50e-15 | -4.63e-01 | -0.2953 |
26517 | TIMM13 | EEC-subject1 | Human | Endometrium | EEC | 1.10e-23 | -4.86e-01 | -0.2682 |
26517 | TIMM13 | EEC-subject2 | Human | Endometrium | EEC | 2.91e-11 | -3.07e-01 | -0.2607 |
26517 | TIMM13 | EEC-subject3 | Human | Endometrium | EEC | 4.96e-64 | -6.24e-01 | -0.2525 |
26517 | TIMM13 | EEC-subject4 | Human | Endometrium | EEC | 1.57e-18 | -4.25e-01 | -0.2571 |
26517 | TIMM13 | EEC-subject5 | Human | Endometrium | EEC | 3.39e-10 | -3.07e-01 | -0.249 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00068398 | Breast | Precancer | mitochondrial transport | 45/1080 | 254/18723 | 1.37e-11 | 1.88e-09 | 45 |
GO:00705858 | Breast | Precancer | protein localization to mitochondrion | 21/1080 | 125/18723 | 9.07e-06 | 2.42e-04 | 21 |
GO:00070066 | Breast | Precancer | mitochondrial membrane organization | 20/1080 | 116/18723 | 9.88e-06 | 2.61e-04 | 20 |
GO:00726558 | Breast | Precancer | establishment of protein localization to mitochondrion | 20/1080 | 120/18723 | 1.66e-05 | 4.03e-04 | 20 |
GO:00901516 | Breast | Precancer | establishment of protein localization to mitochondrial membrane | 8/1080 | 30/18723 | 2.24e-04 | 3.40e-03 | 8 |
GO:00066268 | Breast | Precancer | protein targeting to mitochondrion | 15/1080 | 100/18723 | 5.94e-04 | 7.48e-03 | 15 |
GO:00066059 | Breast | Precancer | protein targeting | 33/1080 | 314/18723 | 6.50e-04 | 7.99e-03 | 33 |
GO:00725948 | Breast | Precancer | establishment of protein localization to organelle | 41/1080 | 422/18723 | 7.75e-04 | 9.20e-03 | 41 |
GO:00512045 | Breast | Precancer | protein insertion into mitochondrial membrane | 6/1080 | 25/18723 | 2.49e-03 | 2.28e-02 | 6 |
GO:0045039 | Breast | Precancer | protein insertion into mitochondrial inner membrane | 4/1080 | 12/18723 | 3.75e-03 | 3.04e-02 | 4 |
GO:000683913 | Breast | IDC | mitochondrial transport | 51/1434 | 254/18723 | 1.54e-10 | 1.83e-08 | 51 |
GO:007058513 | Breast | IDC | protein localization to mitochondrion | 23/1434 | 125/18723 | 6.92e-05 | 1.40e-03 | 23 |
GO:007265513 | Breast | IDC | establishment of protein localization to mitochondrion | 22/1434 | 120/18723 | 1.04e-04 | 1.97e-03 | 22 |
GO:000660514 | Breast | IDC | protein targeting | 43/1434 | 314/18723 | 1.44e-04 | 2.53e-03 | 43 |
GO:000700613 | Breast | IDC | mitochondrial membrane organization | 21/1434 | 116/18723 | 1.78e-04 | 3.00e-03 | 21 |
GO:007259413 | Breast | IDC | establishment of protein localization to organelle | 51/1434 | 422/18723 | 7.94e-04 | 9.55e-03 | 51 |
GO:000662613 | Breast | IDC | protein targeting to mitochondrion | 17/1434 | 100/18723 | 1.47e-03 | 1.50e-02 | 17 |
GO:009015112 | Breast | IDC | establishment of protein localization to mitochondrial membrane | 8/1434 | 30/18723 | 1.48e-03 | 1.50e-02 | 8 |
GO:000683923 | Breast | DCIS | mitochondrial transport | 51/1390 | 254/18723 | 5.04e-11 | 6.79e-09 | 51 |
GO:007058522 | Breast | DCIS | protein localization to mitochondrion | 23/1390 | 125/18723 | 4.28e-05 | 9.05e-04 | 23 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TIMM13 | SNV | Missense_Mutation | c.269N>T | p.Arg90Leu | p.R90L | Q9Y5L4 | protein_coding | deleterious(0) | possibly_damaging(0.713) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
TIMM13 | SNV | Missense_Mutation | c.85N>A | p.Gln29Lys | p.Q29K | Q9Y5L4 | protein_coding | deleterious(0.05) | possibly_damaging(0.794) | TCGA-AP-A0LE-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TIMM13 | SNV | Missense_Mutation | c.70G>A | p.Glu24Lys | p.E24K | Q9Y5L4 | protein_coding | tolerated(0.29) | benign(0.372) | TCGA-AP-A0LM-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
TIMM13 | SNV | Missense_Mutation | c.154N>A | p.Gly52Arg | p.G52R | Q9Y5L4 | protein_coding | tolerated(0.36) | benign(0.048) | TCGA-DD-A4NO-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
TIMM13 | SNV | Missense_Mutation | novel | c.198N>G | p.Ile66Met | p.I66M | Q9Y5L4 | protein_coding | deleterious(0) | probably_damaging(0.937) | TCGA-CN-6011-01 | Oral cavity | head & neck squamous cell carcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | SD |
TIMM13 | SNV | Missense_Mutation | novel | c.88N>G | p.Ile30Val | p.I30V | Q9Y5L4 | protein_coding | tolerated(0.23) | benign(0.268) | TCGA-F7-A50I-01 | Oral cavity | head & neck squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |